James Strenner

James Strenner | President, Europe

James joined the Executive Committee in November 2026 when he was appointed President, Europe. In this role he is responsible for the strategic direction and commercial performance of GSK’s European markets, overseeing a diverse range of medicines and vaccines across more than 30 countries.

James has over two decades of experience at GSK. He most recently served as SVP Enterprise Programmes leading company-wide change initiatives. Previously, James led GSK's US Vaccines Business. He has held senior commercial and strategy roles across multiple geographies, including the US and Asia, and in our Oncology, Vaccines and Respiratory businesses.

He holds a Bachelor's degree in Human Biology from Oxford Brookes University, an MBA from Henley Business School and an Executive Master’s in Change (EMC) from INSEAD.